Utilizing MV-FLOW™ and multidimensional ultrasound characteristics for prognosticating FET outcomes in RIF patients: Study Protocol for a cross-sectional study

Abstract

Recurrent implantation failure (RIF) is a common issue in frozen-thawed embryo transfer (FET). Prior to transfer, uterine endometrial receptivity of FET patients can be assessed using multimodal transvaginal ultrasound indicators to predict the success rate of the current FET cycle. Endometrial blood flow is a crucial element in evaluating endometrial receptivity. MV-FLOW™ is an advanced two-dimensional superb microvascular imaging technology that can detect and display blood flow in micro-vessels. The data for this study were obtained from an ongoing cross-sectional study comprising 323 RIF patients and 323 first implantation (FI) patients, who underwent transvaginal ultrasound before FET. We collected basic clinical data and multimodal ultrasound data from these patients as predictive features, with clinical pregnancy as the predictive label, for model training. Based on the above, this study aims to establish and validate a clinical prediction model for FET outcomes using support vector classification (SVC) algorithms, based on MV-FLOW™ and multidimensional transvaginal ultrasound imaging features. The objective is to determine the predictive role of multimodal transvaginal ultrasound in embryo transfer outcomes and provide evidence for the clinical application of MV-FLOW™. Trial registration: Trial Registration: ChiCTR2400086401.

Fig 1. Study flow chart.

Note: FI, first implantation; RIF, Recurrent implantation failure; ET, embryo transfer.

Fig 2. The schedule of enrolment, interventions, and assessments.

Note: *-t1: Eligibility screen and informed consent before frozen embryo transfer; 0: Allocation at the beginning of frozen embryo; t1: Ultrasound analysis at the day before embryo transfer; t2: Biochemical pregnancy at 14 days following embryo transfer; t3: Clinical pregnancy and embryo implantation at 28 days after embryo transfer.